EverPoint Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

EverPoint Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.29M	Buy	110,000 +10,000	+10%	+$260K	0.04%	316
2016 Q3	$3.28M	Sell	100,000 -250,000	-71%	-$7.61M	0.06%	296
2016 Q2	$8.74M	Sell	350,000 -425,000	-55%	-$11.5M	0.17%	162
2016 Q1	$19M	Buy	775,000 +175,000	+29%	+$4.05M	0.37%	62
2015 Q4	$19.8M	Buy	600,000 +230,000	+62%	+$7.78M	0.42%	60
2015 Q3	$12.1M	Buy	+370,000	New	+$15.7M	0.31%	86
2015 Q1	–	Sell	-83,527	Closed	-$2.43M	–	632
2014 Q4	$2.43M	Buy	+83,527	New	+$1.5M	0.05%	348

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

EverPoint Asset Management's ALDR Position: Q4 2016 in Review

EverPoint Asset Management increased its Alder Biopharmaceuticals (ALDR) stake by 10% in Q4 2016, buying an estimated $260K and bringing the position to 110,000 shares worth $2.29M. The position accounts for 0.04% of the portfolio, ranked #316.

EverPoint Asset Management first reported a position in ALDR in Q4 2014 and has held it in 7 quarters since. The position peaked at $19.8M in Q4 2015. 145 funds tracked by Wall St. Rank hold ALDR as of Q4 2016.

EverPoint Asset Management held 110,000 shares of Alder Biopharmaceuticals worth $2.29M as of Q4 2016.
EverPoint Asset Management bought 10,000 Alder Biopharmaceuticals shares in Q4 2016, an estimated $260K.
Alder Biopharmaceuticals made up 0.04% of EverPoint Asset Management's portfolio in Q4 2016, its #316 holding.
EverPoint Asset Management first reported a position in Alder Biopharmaceuticals in Q4 2014 and has held it in 7 quarters since.
EverPoint Asset Management's Alder Biopharmaceuticals position peaked at $19.8M in Q4 2015.
145 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.